Search

We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.

… Monday, August 26, 2019 Summary After reaching the end of active cancer treatment, some people may assume that going for follow-up tests would be easy. However, the anxiety around having scans can be overwhelming. Anxiety leading up to doctors’ visits and having scans (sometimes referred to as “scanxiety

A new technology shows great promise for imaging and treating advanced forms of prostate cancer.

… Thursday, July 1, 2021 A transformation is coming for patients with prostate cancer , says Memorial Sloan Kettering medical oncologist Michael Morris . Researchers at MSK have helped pioneer major advances that will enable doctors to pinpoint the location of prostate cancer cells more precisely than

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

… Tuesday, May 14, 2013 Summary Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. This image shows melanocytes – cells that protect the skin from ultraviolet radiation – created in a Memorial Sloan Kettering laboratory using

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

… Thursday, July 10, 2025 Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer metastasis remains a stubborn threat. Metastasis is the name for cancer that has spread

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.

… Tuesday, September 8, 2015 Summary Memorial Sloan Kettering is pioneering the use of a noninvasive scanning technique that has the power to reveal whether a tumor is responding to a treatment within just a few days after a patient has started a regimen. This new platform from General Electric Healthcare

Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.

… Tuesday, October 9, 2018 Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols. Abbreviated breast MRI provides high diagnostic accuracy with

Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.

… Monday, June 30, 2025 Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute. Harrington Discovery Institute Scholar-Innovator Awards support the development

One woman’s rare melanoma sparked research led by MSK physician-scientist Rich White involving zebrafish. The surprising results could lead to an entirely new treatment approach.

… Friday, April 1, 2022 Five years ago, MSK physician-scientist Richard White learned about a woman with a rare form of skin cancer on her foot. Called acral melanoma, this type forms on the palms of the hand and soles of the feet and is typically very aggressive. It killed reggae singer Bob Marley. As

Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.

… Friday, October 8, 2021 A significant advance in cancer treatment over the past few years has been the development of the drug sotorasib (Lumakras TM ) for treating people with advanced non-small cell lung cancer . Sotorasib is a targeted therapy that stops the growth of tumors caused by a mutant version

After more than two decades of providing outstanding cancer care to the people of New Jersey, Memorial Sloan Kettering announced today that its newest outpatient treatment center, in Bergen County, will welcome new patients in the coming weeks. In recognition of its debut, MSK’s leadership, joined by members of the community and local elected officials, gathered at the Montvale site to unveil MSK Bergen, a sleek, modern, technology-filled 110,000-plus-square-foot clinical program located on Summit Avenue, mere minutes from the Garden State Parkway.

… Monday, June 25, 2018 After more than two decades of providing outstanding cancer care to the people of New Jersey, Memorial Sloan Kettering announced today that its newest outpatient treatment center, in Bergen County, will welcome new patients in the coming weeks. In recognition of its debut, MSK’s